NASDAQ:ABMD
Delisted
ABIOMED Stock News
$381.02
+0 (+0%)
At Close: Mar 20, 2023
3 Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio
09:02am, Thursday, 22'nd Dec 2022
Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.
Warren Buffett Loves These Stocks. Should You Buy Them Before 2023?
05:30am, Friday, 16'th Dec 2022
There's a lot more ahead for these market giants.
This Monster Dividend Stock Isn't Done Growing
02:00pm, Thursday, 08'th Dec 2022 The Motley Fool
Is another deal on the way for Johnson & Johnson?
Tracking Al Gore's Generation Investment Management Portfolio - Q3 2022 Update
05:23am, Monday, 05'th Dec 2022 Seeking Alpha
Al Gore's 13F portfolio value decreased from $18.35B to $16.86B this quarter. Find out Generation Investment Management's holdings and trades for Q2 2022.
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
10:15am, Friday, 02'nd Dec 2022 The Motley Fool
This space is ripe with opportunities for investors.
Why Is Abiomed (ABMD) Up 1.2% Since Last Earnings Report?
04:31pm, Thursday, 01'st Dec 2022 Zacks Investment Research
Abiomed (ABMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
These 20 stocks soared in November with gains of 22% or more after Powell ignites rally
11:41am, Thursday, 01'st Dec 2022 MarketWatch
Chip makers including AMD and Nvidia rebound on expectations interest rates will rise more slowly.
Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout
06:52pm, Wednesday, 30'th Nov 2022 Benzinga
Horizon Therapeutics Plc (NASDAQ: HZNP) confirmed it's engaged in preliminary talks with Amgen Inc (NASDAQ: AMGN), Janssen Global Service, and Sanofi SA SNY on potential takeover offers for th
Eleven Stocks Turned $10,000 To $261,421 In 11 Months
08:00am, Wednesday, 30'th Nov 2022
Most S&P 500 investors got a little gain this month. But investors willing to look off the beaten path found huge gains.
Here's Why You Should Hold on to Abiomed (ABMD) Stock Now
03:05pm, Tuesday, 22'nd Nov 2022 Zacks Investment Research
Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.
Bear Market Blues? 3 of the Best Stocks to Own in 2023
11:30am, Saturday, 19'th Nov 2022 The Motley Fool
2023 could be a big year for each of these healthcare companies.
2 Warren Buffett Passive Income Stocks You Can Buy to Boost Your Yield
11:06am, Friday, 11'th Nov 2022 The Motley Fool
Buffett loves stocks that pay dividends. Is it any wonder Berkshire Hathaway is poised to collect more than $6 billion worth of them next year?
Better Buy: Johnson & Johnson vs. Abbott Laboratories
02:37pm, Thursday, 10'th Nov 2022 The Motley Fool
These two healthcare giants are among the safest stocks investors can buy right now.
Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed
01:37pm, Thursday, 10'th Nov 2022 The Motley Fool
The company is planting seeds for future growth.
Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed
08:37am, Thursday, 10'th Nov 2022
The company is planting seeds for future growth.
